CRMD
CorMedix Inc
7.70$
+0.0%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | |
| 235.5% | 151.7% | 163.6% | 34.9% | 92.3% | 131.8% | 85.6% | 78.0% | 5.7% | – | 7.3% | 11.5% | |
| -135.5% | -51.7% | -63.6% | 65.1% | 7.7% | -31.8% | 14.4% | 22.0% | 94.3% | – | 92.7% | 88.5% | |
| 696.7% | 2,989.5% | 7,021.4% | 7,435.2% | 4,379.4% | 3,902.0% | 5,591.7% | 6,878.2% | 16,327.6% | – | 9.1% | 6.2% | |
| 3,871.0% | 4,884.4% | 3,963.8% | 2,627.3% | 1,878.7% | 3,482.6% | 5,801.1% | 8,561.3% | 30,586.6% | – | 68.9% | 21.9% | |
| 4,567.8% | 7,873.9% | 10,985.2% | 10,062.5% | 6,258.1% | 7,384.5% | 11,392.8% | 15,439.5% | 46,914.2% | – | 144.1% | 40.3% | |
| -4,703.3% | -7,925.6% | -11,048.8% | -9,997.4% | -6,250.4% | -7,416.3% | -11,378.4% | -15,417.5% | -46,819.9% | – | -51.4% | 48.2% | |
| 1.1% | 1.9% | 0.6% | 1.7% | 0.4% | 278.0% | 13.9% | 8.3% | 40.5% | – | 0.1% | 0.9% | |
| -10,806.3% | -8,655.4% | -10,996.5% | -10,023.4% | -6,242.4% | -4,014.7% | -11,368.5% | -15,429.5% | -46,305.2% | – | -44.5% | 48.1% | |
| 1.1% | 1.9% | 0.6% | -9.5% | 8.5% | 1,786.6% | -2,160.8% | -654.8% | -895.3% | – | -3.2% | -4.2% | |
| -10,806.3% | -8,655.4% | -10,996.5% | -10,023.4% | -6,242.4% | -5,801.3% | -9,207.7% | -14,774.7% | -45,409.9% | – | -41.2% | 52.3% | |
| -10,797.2% | -8,646.3% | -10,985.0% | -10,012.2% | -6,224.7% | -7,390.4% | -11,294.7% | -15,385.1% | -45,945.1% | – | -43.7% | 53.8% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.